The Pathophysiology and Management of Thrombotic Thrombocytopenic Purpura

Eur J Haematol. 1996 Apr;56(4):191-207. doi: 10.1111/j.1600-0609.1996.tb01930.x.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Blood Transfusion
  • Child
  • Endothelium, Vascular / injuries
  • Endothelium, Vascular / pathology
  • Female
  • Hemolytic-Uremic Syndrome / physiopathology
  • Humans
  • Immunosuppression
  • Male
  • Microcirculation
  • Middle Aged
  • Neoplasms / complications
  • Oxidative Stress
  • Plasma
  • Plasma Exchange
  • Platelet Aggregation
  • Platelet Aggregation Inhibitors / therapeutic use
  • Pregnancy
  • Pregnancy Complications, Hematologic / physiopathology
  • Pregnancy Complications, Hematologic / therapy
  • Purpura, Thrombotic Thrombocytopenic / etiology
  • Purpura, Thrombotic Thrombocytopenic / physiopathology*
  • Purpura, Thrombotic Thrombocytopenic / therapy
  • Splenectomy
  • Survival Rate
  • von Willebrand Factor / metabolism

Substances

  • Platelet Aggregation Inhibitors
  • von Willebrand Factor